671 related articles for article (PubMed ID: 19760968)
1. Ampullary cancer and preoperative jaundice: possible indication of the minimal surgery.
Uchida H; Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
Hepatogastroenterology; 2009; 56(93):1194-8. PubMed ID: 19760968
[TBL] [Abstract][Full Text] [Related]
2. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
3. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Jang JY; Kim SW; Kang GH; Yoon YB
Ann Surg Oncol; 2007 Nov; 14(11):3195-201. PubMed ID: 17710498
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and operative factors for prognosis of carcinoma of the ampulla of vater.
Inoue Y; Hayashi M; Hirokawa F; Egashira Y; Tanigawa N
Hepatogastroenterology; 2012; 59(117):1573-6. PubMed ID: 22683975
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of the ampulla of Vater: results of surgical treatment of a single center.
Memon MA; Shiwani MH; Anwer S
Hepatogastroenterology; 2004; 51(59):1275-7. PubMed ID: 15362731
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; DomÃnguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
9. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
[TBL] [Abstract][Full Text] [Related]
10. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.
Schwarz RE; Keny H
Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of surgical treatment for ampullary carcinoma.
Shinkawa H; Takemura S; Kiyota S; Uenishi T; Kaneda K; Sakae M; Urata Y; Ohata K; Nozawa A; Kubo S
Hepatogastroenterology; 2012 Jun; 59(116):1010-2. PubMed ID: 22580650
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
13. Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma.
Lee JH; Lee KG; Ryou H; Jun YJ; Paik SS; Park HK; Lee KS
Hepatogastroenterology; 2010; 57(99-100):646-52. PubMed ID: 20698243
[TBL] [Abstract][Full Text] [Related]
14. Pathological factors influencing survival of carcinoma of the ampulla of Vater.
Mori K; Ikei S; Yamane T; Yamaguchi Y; Katsumori T; Shibata Y; Arai T
Eur J Surg Oncol; 1990 Jun; 16(3):183-8. PubMed ID: 2347413
[TBL] [Abstract][Full Text] [Related]
15. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma.
Wang CH; Mo LR; Lin RC; Kuo JJ; Chang KK; Lin YW; Yang DM; Yau MP; Cho CY
Hepatogastroenterology; 2004; 51(59):1495-9. PubMed ID: 15362785
[TBL] [Abstract][Full Text] [Related]
16. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma.
Kim RD; Kundhal PS; McGilvray ID; Cattral MS; Taylor B; Langer B; Grant DR; Zogopoulos G; Shah SA; Greig PD; Gallinger S
J Am Coll Surg; 2006 Jan; 202(1):112-9. PubMed ID: 16377504
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients with carcinoma of the papilla of Vater.
Tanaka S; Hirohashi K; Tanaka H; Yamamoto T; Kubo S; Shuto T; Takemura S; Kinoshita H
Hepatogastroenterology; 2002; 49(46):1116-9. PubMed ID: 12143216
[TBL] [Abstract][Full Text] [Related]
18. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
20. Survival after resection of ampullary carcinoma: a national population-based study.
O'Connell JB; Maggard MA; Manunga J; Tomlinson JS; Reber HA; Ko CY; Hines OJ
Ann Surg Oncol; 2008 Jul; 15(7):1820-7. PubMed ID: 18369675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
